Covidien says the FDA granted 510(k) clearance for its HawkOne atherectomy device.
Covidien agrees to deal its Stellarex drug-coated balloon to Spectranetics for $30 million is it looks to satisfy U.S. anti-trust regulators ahead of a $43 billion merger with Medtronic.
Medtronic CEO Omar Ishrak unveils the plan for the medical device giant's management structure after it closes its mega-merger with Covidien early next year.
Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic updates on $43B Covidien deal financing; Boston Scientific, Bard CEOs cool on consolidation; Nevro sets range for IPO of up to $106m; Alere to sell Alere Health unit to Optum for $600m; Skyline Medical conducts 1-for-75 reverse stock split
Medtronic and Covidien say their pending, $43 billion merger is expected to close in early 2015.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Covidien plans to sell some vascular therapies ahead of Medtronic merger; Covidien, Medtronic shares jump on affirmation of $43B merger; Wright Medical to acquire Tornier for $3.3B in inversion deal; Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic; Globus Medical snaps up allograft maker Transplant Technologies
Covidien unveils the next generation of its superDimension device for lung imaging procedures.
Covidien (NYSE:COV) today unveiled the next generation of its superDimension navigation software for lung procedures.